APOA1 and autoimmune polyendocrinopathy: Anti-apoA-1 IgG were first identified in 1998 by Dinu and colleagues who demonstrated that high levels of those autoantibodies were found in a significant subset of SLE (32.5%) and primary APS patients (22.9%) and displayed a high affinity to nascent and mature HDL molecules [10].